DIRECTA PLUS PLC — Capital/Financing Update 2021

Aug 2, 2021

National Storage Mechanism | Additional information

RNS Number : 1590H

Directa Plus PLC

02 August 2021

2 August 2021

Directa Plus plc

("Directa Plus" or the "Company")

Italian Government Covid-19 Recovery Loans

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that its Italian subsidiary, Directa Plus S.p.A., has qualified for a total of €0.7m in loans under the Italian Government's Covid-19 Recovery Plan.

The Company took advantage of the low-cost liquidity offered by the Italian Government in order to accelerate its strategic programme.

The funds are being provided in two tranches by Intesa Sanpaolo S.p.A.: a €0.5m loan and a €0.2m leasing loan to fund the acquisition of new machinery for the Company's production facility.

The loans have a term of 5-6 years, a variable interest rate of 1.5-1.8% +EURIBOR 3M and are 80-90 per cent. guaranteed by the Italian Government.

Exploiting the same government measure the company is negotiating with another major Italian bank an additional € 0.5m loan. Further announcements will be made in due course.

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus said: "This measure offered by the Italian Government to respond to COVID crisis will be utilised by Directa to accelerate activities in areas where our G+ graphene has a significant competitive advantage like environmental, batteries, anti-viral and anti-bacterial textiles."

For further information please visit http://www.directa-plus.com/ or contact:

Directa Plus plc	+39 02 36714458
Giulio Cesareo, CEO Giorgio Bonfanti, CFO
Cenkos Securities plc (Nominated Adviser and Joint Broker)	+44 131 220 6939
Neil McDonald Pete Lynch
N+1 Singer (Joint Broker)	+44 20 7496 3069
Rick Thompson Phil Davies
Tavistock (Financial PR and IR)	+44 20 7920 3150
Simon Hudson Heather Armstrong

About Directa Plus

Our focus is principally on the two sectors in which we have strong commercial advantage through developed and launched products and a technological lead: environmental (based on our Grafysorber® product), textiles (based on our G+® products) and, more recently, lithium-sulphur batteries.  In addition, we will continue to pursue opportunities in elastomers and composites (including tyres and asphalt), also using our G+® products.  All our products are hypoallergenic, non-toxic and sustainably produced.

-ends-

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCUPURGRUPGGRG